Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics | |
Zhu Liang; Xue Hua-Dan; Liu Wei; Wang Xuan; Sui Xin; Wang Qin; Zhang Daming; Li Ping; Jin Zheng-Yu | |
2017 | |
卷号 | 122期号:5页码:337-344 |
关键词 | CA19-9 Diagnosis Multidetector computed tomography Pancreatic neoplasms |
ISSN号 | 1826-6983 |
DOI | 10.1007/s11547-017-0734-x |
URL标识 | 查看原文 |
收录类别 | PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6367556 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhu Liang,Xue Hua-Dan,Liu Wei,et al. Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics[J],2017,122(5):337-344. |
APA | Zhu Liang.,Xue Hua-Dan.,Liu Wei.,Wang Xuan.,Sui Xin.,...&Jin Zheng-Yu.(2017).Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics.,122(5),337-344. |
MLA | Zhu Liang,et al."Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics".122.5(2017):337-344. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论